Organon (OGN) Prepaid Assets (2020 - 2026)
Organon (OGN) recorded quarterly Prepaid Assets of $1.1 billion in Q1 2026, up 2.52% quarter-over-quarter from $1.0 billion in Q4 2025, and up 5.37% on a YoY basis from $1.0 billion in Q1 2025.
Organon (OGN) Prepaid Assets (2020 - 2026) Analysis & Trends
Organon's Prepaid Assets history runs 7 years deep, the most recent figure standing at $1.1 billion for Q1 2026.
- In Q1 2026, Prepaid Assets rose 5.37% year-over-year to $1.1 billion; the TTM figure through Mar 2026 stood at $1.1 billion (up 5.37% YoY), while the FY2025 annual figure was $1.0 billion, up 3.92% from the prior year.
- Prepaid Assets was $1.1 billion for Q1 2026 at Organon, up from $1.0 billion in the prior quarter.
- In the past five years, Prepaid Assets ranged from a high of $1.1 billion in Q2 2025 to a low of $747.0 million in Q4 2022.
- Historically, Prepaid Assets has averaged $882.7 million across 5 years, with a median of $811.0 million in 2024.
- The sharpest annual moves came in 2022 and 2024: Prepaid Assets retreated 14.48% in 2022, then soared 31.48% in 2024.
- A 5-year view of Prepaid Assets shows it stood at $747.0 million in 2022, then gained by 1.2% to $756.0 million in 2023, then jumped by 31.48% to $994.0 million in 2024, then rose by 3.92% to $1.0 billion in 2025, then advanced by 2.52% to $1.1 billion in 2026.
- The last three Prepaid Assets figures came in at $1.1 billion (Q1 2026), $1.0 billion (Q4 2025), and $1.1 billion (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.06 Bn |
| Dec 31, 2025 | 1.03 Bn |
| Sep 30, 2025 | 1.06 Bn |
| Jun 30, 2025 | 1.08 Bn |
| Mar 31, 2025 | 1.01 Bn |
| Dec 31, 2024 | 994.00 Mn |
| Sep 30, 2024 | 925.00 Mn |
| Jun 30, 2024 | 901.00 Mn |
| Mar 31, 2024 | 811.00 Mn |
| Dec 31, 2023 | 756.00 Mn |
| Sep 30, 2023 | 802.00 Mn |
| Jun 30, 2023 | 761.00 Mn |
| Mar 31, 2023 | 755.00 Mn |
| Dec 31, 2022 | 747.00 Mn |
| Sep 30, 2022 | 774.00 Mn |
| Jun 30, 2022 | 789.00 Mn |
| Mar 31, 2022 | 757.00 Mn |
| Dec 31, 2021 | 726.00 Mn |
| Sep 30, 2021 | 905.00 Mn |
| Jun 30, 2021 | 803.00 Mn |